当前位置: 首页 > 期刊 > 《中国健康月刊·B版》 > 2010年第10期 > 正文
编号:12017324
HIF-1a VEGF在子宫内膜腺癌中的表达与意义(3)
http://www.100md.com 2010年10月1日 武玉巧
第1页

    参见附件(2277KB,3页)。

     [3] Sivridis E,Giatromanolaki A,Gatter KC,et al,Association of hypoxia inducible factor I apha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma Cancer,2002,95(5):1055-1063.

    [4] Asc G,Xu X,chu C,et al.prognosic significance of erythropoietin expression in Human endometrial Carcinoma.cancer,2004,100(11):2376-2386.

    [5] Holderfield MT, Hughes CC. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factorbeta in vascular morphogenesis. Circ Res,2008, 102 (6): 637-652

    [6] Neid M, Datta K, Stephan S, et al. Role of insulinreceptor substrates and protein kinase Czeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem2004, 279 (6): 3941-3948

    [7] Gort EH, Groot AJ, Van der WE, et al. Hypoxic regulation of metastasis via hypoxiainducible factors.Curr Mol Med, 2008, 8 (1): 60-67

    [8]Ziello JE, Jovin IS, Huang Y. HypoxiaInducible Factor (HIF) 1 regulatory pathway and its potential for therapeutic intervention in m alignancy and ischemia. Yale J Biol Med, 2007, 80 (2): 51-60 liferation and tumor angiogenesis.Nature,1998,394(6692):485-490.

您现在查看是摘要介绍页,详见PDF附件(2277KB,3页)